The Cardiovascular Dynamics section is led by Xavier Monnet.
The novelty for 2023 is the progressive approach for better integration of what is being learnt in Haemodynamics, offering our participants the possibility to choose based on their needs, skill and aims.
Level 1: Foundation Course (Introductory)
Dates: 18-19 April, 2023
Join this course if you wish to have an introductory view of the field of cardiovascular physiology, with a focus on physiology, fluid therapy fundamentals, basic pharmacotherapy of shock states, clinical indices of shock state and tissue malperfusion, interpretation of arterial pressure, and cardiac output monitoring.
IMPORTANT! A total of 10 places will be offered for FREE to participants coming from Low and Lower Middle-Income Countries (LMICs). Deadline for LMIC applications: March 19, 2023.
Level 2: Transition Course
Dates: 21-22 June, 2023
This course provides participants with a solid view of the field of cardiovascular physiology, assessment of tissue oxygenation, fluid therapy and other treatments. A high level of interaction is the core feature of these 2 days of learning. This will be guaranteed thanks to interactive lectures, focus sessions, case-based discussions, gamification and immersive learning through virtual reality.
Level 3: Master Course (integration and simulation)
Format: Pre-congress Course at LIVES 2023 (Milan, Italy)
Dates: 21-22 October, 2023
This course will integrate at an advanced level topics such as the effects of intra-abdominal pressure, hemodynamic effects of ARDS, fluid overload & restrictive fluid resuscitation, venous effects of norepinephrine, ECMO, HLI in ARDS, effects of PEEP, weaning-induced pulmonary oedema and much more.
The novelty for 2023 is the progressive approach for better integration of what is being learnt in ECLS/ECMO, offering our participants the possibility to choose based on their needs, skill and aims.
These courses are part of a joint EuroELSO & ESICM programme to provide specialised training in extracorporeal techniques to healthcare professionals interested in the field. Certificates may be validated at EuroELSO on the path to the ELSO Adult ECMO Practitioner Certification (E-AEC).
These courses will bring together a panel of worldwide known EuroELSO & ESICM experts.
Level 1: Foundation Course (Introductory)
Dates: 8-9 March, 2023
Study ECMO/ECLS, ECMO circuit, canulation for adult cardiac & respiratory ECMO, anticoagulation on ECMO, as well as fundamentals on ECMO for Adult Respiratory & Cardiac Failure.
IMPORTANT! A total of 10 places will be offered for FREE to participants coming from Low and Lower Middle-Income Countries (LMICs). Deadline for LMIC applications: February 12, 2023.
Level 3.1: Master course (integration and simulation)
Dates: 4-5 July, 2023
Get a solid view of ECLS/ECMO with a focus on weaning from VV ECMO and VA ECMO, patient-related VA ECMO complications (differential oxygenation – limb ischaemia – LV overload), awake ECMO (potential benefits and pitfalls) and much more.
Level 3.2: Focus session
Format: Pre-congress course at LIVES 2023 (Milan, Italy)
Dates: 21-22 October, 2023
This session will integrate topics such as ECMO-ventilator interactions in respiratory ECMO & unloading the left ventricle in peripheral cardiac ECMO.
Free live webinars are available for members & non members on the ESICM Media Library.
FENICE (Fluid Challenges in Intensive Care) is a multicentre observational trial designed and conducted by the ESICM Trials Group to investigate how fluids are administered in critically ill patients.
The purpose of this study is to evaluate how fluids are administered and how frequently fluid administration results in a positive haemodynamic response.
Fluid challenges in intensive care: the FENICE study – A global inception cohort study.
The ICU CardioMan Study
Cardiovascular Monitoring & Management in Austrian, German and Swiss Intensive Care Units. The objective of this multicentre study was to analyse the reality of haemodynamic monitoring and therapy of the critically ill in Austrian, German and Swiss intensive care units. This included acquisition of data on which types of haemodynamic monitoring clinicians have available in their ICU.
This study also aimed to investigate which indications lead to therapy decisions and/or extension of haemodynamic monitoring and which parameters serve as therapeutic goals. Additionally, this study investigated how the extension of haemodynamic monitoring guides and modifies therapeutic decisions and strategies in clinical practice.
Funcke S et al. Practice of haemodynamic monitoring and management in German, Austrian, and Swiss intensive care units: the multicentre cross-sectional ICU-CardioMan Study.
- ECHO Project Group: VIEILLARD-BARON Antoine
> To promote and support research and education on echocardiography in ICU.
- Haemodynamic monitoring: MONNET Xavier
> To promote and support research and education on haemodynamic monitoring in ICUs.
- Monitoring of sublingual microcirculation
Use of CARdiovascular Drugs in Shock. In shock, organs are hypoperfused leading to dysfunction or death at a cellular level, as well as disruption in cardiovascular functions. Cardiovascular drugs are often used to manage patients in this state, despite the lack of consensus on their use.
This survey from the Cardiovascular Dynamics Section aimed to evaluate the indications, current practice, and therapeutic goals in European ICUs on the use of cardiovascular drugs in the treatment of shock states.
Publication: Scheeren T.W.L et al. 2019. Current use of vasopressors in septic shock
Intra-abdominal Hypertension and Abdominal Compartment Syndrome World Survey.
This survey, endorsed by ESICM and WSACS, is part of a research project which aims to determine the impact, if any, of the 2013 World Society of the Abdominal Compartment Syndrome (WSACS) IAH/ACS Consensus Definitions/Clinical Management Guidelines, IAP measurement practices, on IAH/ACS clinical awareness and management.
Results from this survey will be compared with those obtained from a similar survey conducted in 2007.
This project was conducted by Dr RD Wise, a member of the WSCAS Clinical Trials Working Group, supported by WSACS and led by Pr Manu Malbrain.
Red Cell Transfusion
Variation in red cell transfusion practice in the ICU: an international survey.
The INOX-ICU 1 team: S. A Willems Bsc, Sesmu Arbous MD/PhD, Prof. J. Kesecioglu MD/PhD, Prof. J. van der Bom MD/PhD, Prof. S. le Cessie PhD, P.J. Marang-van de Mheen PhD, F. Kranenburg MD/PhD
This survey aims to estimate the extent of variation in transfusion decisions within four clinical scenarios. This knowledge can add to further improve personalised care with respect to transfusion practice in critically ill patients.
Hernandez G. et al. Invasive arterial pressure monitoring: much more than mean arterial pressure! Intensive Care Med. 2022 Oct;48(10):1495-1497.
De Backer D. et al. How can assessing hemodynamics help to assess volume status? Intensive Care Med. 2022 Oct;48(10):1482-1494.
Hamzaoui O. and Teboul J-L. Central venous pressure (CVP). Intensive Care Med. 2022 Oct;48(10):1498-1500.
Cour M. et al. Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial. Intensive Care Med. 2022 Sep 14.
Dung-Hung C. et al. External validation of a machine learning model to predict hemodynamic instability in intensive care unit. Crit Care. 2022 Jul 14;26(1):215.
Shi R. et al. Tidal volume challenge to predict preload responsiveness in patients with acute respiratory distress syndrome under prone position. Crit Care. 2022 Jul 18;26(1):219.
Gavelli F. et al. Extravascular lung water levels are associated with mortality: a systematic review and meta-analysis. Crit Care. 2022 Jul 6;26(1):202.
Meyhoff T.S. et al. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl J Med. 2022 Jun 30;386(26):2459-2470.
Legrand M. and Zarbock A. Ten tips to optimize vasopressors use in the critically ill patient with hypotension. Intensive Care Med. 2022 Jun;48(6):736-739.
Slobod D. et al. Right Ventricular Loading by Lung Inflation during Controlled Mechanical Ventilation. Am J Respir Crit Care Med. 2022 Jun 1;205(11):1311-1319.
Ahuja S. et al. Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients – insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis. Crit Care. 2022 Jun 1;26(1):157.
Messina A. et al. Fluid challenge in critically ill patients receiving haemodynamic monitoring: a systematic review and comparison of two decades. Crit Care. 2022 Jun 21;26(1):186.
Raia L. et al. Impaired skin microvascular endothelial reactivity in critically ill COVID-19 patients. Ann Intensive Care. 2022 Jun 13;12(1):51.
Monnet X. et al. Prediction of fluid responsiveness. What’s new? Ann Intensive Care. 2022 May 28;12(1):46.
Zarrabian B. et al. Liberation from Invasive Mechanical Ventilation with Continued Receipt of Vasopressor Infusions. Am J Respir Crit Care Med. 2022 May 1;205(9):1053-1063.
Bougouin W. et al. Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock. Intensive Care Med. 2022 Mar;48(3):300-310.
Wieruszewski P.M. and Khanna A.K. Vasopressor Choice and Timing in Vasodilatory Shock. Crit Care. 2022 Mar 22;26(1):76.
Bakker J. et al. Current practice and evolving concepts in septic shock resuscitation. Intensive Care Med. 2022 Feb;48(2):148-163.
Huang H. et al. Value of variation of end-tidal carbon dioxide for predicting fluid responsiveness during the passive leg raising test in patients with mechanical ventilation: a systematic review and meta-analysis. Crit Care. 2022 Jan 14;26(1):20.
Finfer S. et al. Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults. N Engl J Med. 2022 Jan 18. doi: 10.1056/NEJMoa2114464.
Zampieri F.G. et al. Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA. 2021 Sep 7;326(9):830-838. doi: 10.1001/jama.2021.11444.
Zampieri F.G. et al. BaSICS investigators and the BRICNet members. Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA. 2021;326(9):1–12. doi: 10.1001/jama.2021.11684.
Antequera Martín A.M. Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children. Cochrane Database Syst Rev. 2019 Jul 19;7(7): CD012247. doi: 10.1002/14651858.
A new perspective for Oxygen Therapy in Suspected Acute Myocardial Infarction
The DETO2X-AMI is the largest trial to date investigating the effect of oxygen therapy in patients with suspected IMA with no hypoxaemia at baseline, both in the prehospital and hospital setting.
Angiotensin II for the Treatment of Vasodilatory Shock
Vasodilatory shock is a severe clinical condition characterised by acute reduction of vascular resistance leading to systemic hypoperfusion, multi-organ dysfunction and death.
Conservative fluid management: Turn off the tap after use?
In the recently published updated guidelines by the Surviving Sepsis Campaign, fluid administration is the mainstay of initial resuscitation of septic patients and it should be performed early
Restricting volumes of resuscitation fluid in adults with septic shock: CLASSIC Trial
The administration of fluid optimises intravascular volume and perfusion pressure of vital organs, excessive fluid administration can be detrimental.
Cardiac output measurements: Echocardiography vs. thermodilution
The clinical standard is considered to be intermittent thermodilution technique based on the Stewart–Hamilton equation. This technique has its limitations, including variability in serial measurements of CO and rare, but potentially serious, complications.